Active

Apogem Capital

Investor type

Debt fund / VC / PE

Founded

2022

AUM

$44 000 M

Location

New York, New York, United States

Investment Ticket

$10-50 m

Investment Stage

Pre-seed Seed Series A Series B Late Stage (Series C+)

Region of investment

North America
Investor profile last updated: 09 September, 2026

Profile

Apogem Capital is a private markets investor and strategic partner based in New York, known for its focus on the middle and lower middle markets. With a history spanning over 25 years, Apogem operates as a part of New York Life through New York Life Investment Management Holdings. The firm employs more than 250 professionals, including over 120 investment officers, and prides itself on its deep industry relationships and strategic insights across multiple market cycles.

Apogem Capital invests through a range of strategies, including private equity, direct lending, GP stakes, and private real assets. The firm targets emerging fund managers, independent sponsors, and direct investments primarily within North America. With approximately $44 billion in assets under management, Apogem addresses the needs of a diverse client base, including pension funds, family offices, and high net worth investors. Their investment approach spans sectors such as Financial Services, Industrial, Healthcare Services, and Technology, with typical check sizes ranging from $10 to $50 million.

Notable investments include positions in emerging management funds and direct company investments, leveraging its comprehensive platform to provide value and growth. The firm's reputation is built on its ability to navigate volatile market environments, maintaining rigorous underwriting discipline to consistently deliver attractive returns and strategic growth opportunities.

Industry

HealthTech CleanTech Energy Technology Real Estate Industrial Healthcare Services Fintech Financial Services Business Services (B2B) Consumer Products Consumer Services (B2C) SaaS Software Security

Apogem Capital Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Apogem Secondary Fund VII
Private Equity (PE)
Financial Services
Fintech
Healthcare Services
Energy
CleanTech
HealthTech
Pre-seed
Seed
North America
$5-10 m
$776 M
February 2025
PA Secondary Fund VI
Private Equity (PE)
Healthcare Services
Energy
HealthTech
Series B
Late Stage (Series C+)
North America
$5-10 m
$614 M
June 2022
PA Small Company Private Equity Fund IX
Private Equity (PE)
Business Services (B2B)
Consumer Products
Consumer Services (B2C)
Healthcare Services
SaaS
Software
Technology
Series B
Late Stage (Series C+)
North America
$5-10 m
$673 M
March 2015
PA Secondary Fund V
Private Equity (PE)
Healthcare Services
Industrial
SaaS
Security
Software
Technology
Series B
Late Stage (Series C+)
North America
$5-10 m
$14 M
March 2016
Apogem Private Equity Fund XI
Private Equity (PE)
Venture Capital (VC)
Debt fund
Financial Services
Fintech
Healthcare Services
Energy
HealthTech
Series B
Late Stage (Series C+)
North America
$5-10 m
$75 M
May 2026

Contacts

Name
Title
Email
avatar
Brendan Bostock Vice President
Vice President
b•••@•••
avatar
Ryan Bowles Vice President
Vice President
r•••@•••
Upgrade to see contacts
avatar
eaoAj6O8z2irwSpK eaoAj6O8z2irwSpK
eaoAj6O8z2irwSpK
avatar
eaoAj6O8z2irwSpK eaoAj6O8z2irwSpK
eaoAj6O8z2irwSpK
avatar
eaoAj6O8z2irwSpK eaoAj6O8z2irwSpK
eaoAj6O8z2irwSpK
Investment-team contacts for Apogem Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Apogem Capital

Apogem Capital is a venture capital and private equity firm that also operates as a debt fund. It backs companies at Pre-seed, Seed, Series A, Series B and Late Stage (Series C+), writing tickets of $10-50 m.
Apogem Capital is located in New York, New York, United States.
Apogem Capital was founded in 2022.
Apogem Capital invests in companies and startups in HealthTech, CleanTech, Energy, Technology, Real Estate, Industrial, Healthcare Services, Fintech, Financial Services, Business Services (B2B), Consumer Products, Consumer Services (B2C), SaaS, Software, Security.
Apogem Capital invests in companies and startups in North America.
Apogem Capital invests in companies and startups at Pre-seed, Seed, Series A, Series B, Late Stage (Series C+).
Apogem Capital usually invests $10-50 m on average.
Apogem Capital has around $44 000m assets under management.
Apogem Capital last fund was created/launched in 2026-09-09
Apogem Capital can be reached through its website apogemcapital.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Apogem Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Apogem Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 09 September, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.